Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced updated efficacy and safety ...
GlobalData on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
4don MSN
Autologous T cell therapy targeting multiple antigens shows promise in treating pancreatic cancer
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...
A Las Vegas hospital has achieved a major milestone as staff celebrates the completion of its 100th stem cell transplant. The ...
It's Blossom on MSN
Food & Drug Experts Say New Kidney Cell Therapy Could Transform Chronic Disease Treatment
ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...
This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...
Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...
News-Medical.Net on MSN
Recent advances in CAR-NK cell therapy could revolutionze cancer treatment
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Highlights from JPMorgan's 2026 healthcare conference cover patient cash payments for obesity drugs, renewed biotech IPO ...
Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...
China: CAR T-cell therapy, already in use for certain B-cell–driven autoimmune diseases such as lupus, has now demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback